Author： Dean Hansi J
Publisher： Informa Healthcare
ISSN： 1742-5247
Source： Expert Opinion on Drug Delivery, Vol.3, Iss.5, 2006-09, pp. : 557-561
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The global emergence of virulent avian influenza and the concomitant raised threat of an influenza pandemic has increased interest in the development of improved influenza vaccines. Whereas conventional influenza vaccines are delivered by parenteral injection, an intranasal influenza vaccine has been marketed since 2003. Many other technologies are in development for intranasal, oral, epidermal and topical influenza vaccines. This editorial summarises the advances in clinical development of technologies for needle-free influenza vaccine delivery.
Related content
Access to resources
Recommend
The influenza vaccine licensing process
Vaccine, Vol. 21, Iss. 16, 2003-05 ,pp. :
Periocular routes for retinal drug delivery
By Raghava Swita Hammond Makena Kompella Uday B
Expert Opinion on Drug Delivery, Vol. 1, Iss. 1, 2004-11 ,pp. :
The annual production cycle for influenza vaccine
By Gerdil C.
Vaccine, Vol. 21, Iss. 16, 2003-05 ,pp. :
Strategies for DNA vaccine delivery
By Alpar H Oya Papanicolaou Irene Bramwell Vincent W
Expert Opinion on Drug Delivery, Vol. 2, Iss. 5, 2005-09 ,pp. :